COCOA, Fla., Nov. 5, 2019 /PRNewswire/ -- AVO T&L, LLC and 

NASHVILLE, Tenn., Nov. 5, 2019 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release third quarter 2019 financial results after the market closes on Tuesday, November 12, 2019.  A conference call and live Internet webcast will be held on Tuesday, November 1

BOSTON, Nov. 5, 2019 /PRNewswire/ -- Today, over 80 million Americans do not have access to employer sponsored benefits leaving them in a vulnerable position. Additionally, 21% of Americans have saved $0 for retirement, and 27 million Americans lack health insurance.Using Catch, individuals are able to own and manage their benefits in

ENGLEWOOD CLIFFS, N.J., Nov. 5, 2019 /PRNewswire/ -- Enzychem Lifesciences Corporation (KOSDAQ: 183490), a South Korean biopharmaceutical company dedicated to developing transfor

TEL AVIV, Israel, Nov. 5, 2019 /PRNewswire/ -- Celebrity-backed CBD (Cannabidiol) brands are driving the industry to new heights and Leafreport, a transparent and unbiased CBD information hub just released its highly anticipated

PHOENIX, Nov. 5, 2019 /PRNewswire/ -- Harvest Health & Recreation, Inc. (CSE: HARV, OTCQX: HRVSF) ("Harvest") and Verano Holdings, LLC ("Verano") hav

LOS ANGELES, Nov. 5, 2019 /PRNewswire/ -- Premier global nutrition company, Herbalife Nutrition (NYSE:HLF), and Proactive Sports Performance plan to extend their long-time partnership and take sports performance to a new level by opening Herbalife Nutrition's first global state-of-the-art performance center, in Westlake Village, California

DALLAS, Nov. 5, 2019 /PRNewswire/ -- With an estimated 2 million people in the United States living with a substance-use disorder related to prescription opioid pain medication, Ex-hospital CEO, Ty Burgess is on a mission to decrease that number. Ty understands the issue well, having a history

HUNTSVILLE, Ala., Nov. 5, 2019 /PRNewswire/ -- Discovery Life SciencesTM (Discovery) today announced the acquisition of QualTek Molecular Laboratories (QualTek), a renowned provider of immunohistochemistry (IHC) services with CAP/CLIA-accredited and Good Laboratory Practice-(GLP) capable laboratories in California and

SAN DIEGO, Nov. 5, 2019 /PRNewswire/ -- Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company leveraging proprietary non-viral gene engineering technologies to create life-saving therapeutics, today announced it will present preclinical research findings during the Society for Immunotherapy of Cancer (SITC) 34th